Home / India / India’s second coronavirus vaccine candidate approved for human trials
India's second coronavirus vaccine candidate approved for human trials

India's second coronavirus vaccine candidate approved for human trials

AHMEDABAD: Zydus, part of Ahmedabad-based Cadila Healthcare, on Friday said it received approval from the Drugs Controller General of India to conduct Phase I and II human clinical trials for its Covid-19 vaccine candidate ‘ZyCoV-D’.

This is the second Indian vaccine candidate to get approval for human trials.

Zydus said the potential vaccine showed a “strong immune response” in animal studies.

On June 29, Hyderabad-based Bharat Biotech said its COVID-19 vaccine candidate ‘COVAXIN’ has received approval from the Drugs Controller General of India (DCGI) to conduct Phase I and II human trials.

This made ‘COVAXIN’ India’s first vaccine candidate to receive approval for human trials. The vaccine is developed in collaboration with the ICMR and the National Institute of Virology.

Get Breaking news and Latest News from India and around the world on GlobalPunjabTV.net. Follow us on Facebook for more updates.

Check Also

SAD demands CVC inquiry into charges of Rs 2k crore despatched to Cong by liquor & sand mafia

SAD workers march to Raj Bhawan & court arrest for third consecutive day

CHANDIGARH, AUGUST 10: The Shiromani Akali Dal (SAD) on Sunday held a protest march to …

Leave a Reply

Your email address will not be published. Required fields are marked *